Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Long-Term Follow-Up Study of Gamgertamig

This study will follow adults who previously received gamgertamig in another clinical study to evaluate long-term safety and clinical outcomes.

Participants needed: 100
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Lakefront Biotherapeutics West LLCUpdated: Sep 29, 2026
Eligibility criteria

Completed the protocol-defined treatment regimen in an eligible parent gamgertam... [+2]

Not applicable.

Status: Recruiting

OM336 in Autoimmune Cytopenias

An early-phase clinical trial evaluating the safety, tolerability, and pharmacokinetics of subcutaneously dosed OM336 in adult participants with autoimmune cytopenias.

Participants needed: 32
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Lakefront Biotherapeutics West LLCUpdated: Sep 3, 2026Locations: 7
Eligibility criteria

Active autoimmune cytopenia [+3]

Previous treatment with a BCMA-targeted therapy [+3]